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Background:MAP3K8 (Cot/tpl2) activatesMKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1
receptor superfamily.
Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory
signals induced by necrotic cells.
Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2.
Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-
associated molecular patterns.
Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following
stimulation of the Toll-like/IL-1 receptor superfamily. Here, we
investigated the role of Cot/tpl2 in sterile inflammation and
drug-induced liver toxicity. Cot/tpl2 KO mice exhibited
reduced hepatic injury after acetaminophen challenge, as evi-
denced by decreased serum levels of both alanine and aspartate
aminotransferases, decreased hepatic necrosis, and increased
survival relative to Wt mice. Serum levels of both alanine and
aspartate aminotransferases were also lower after intraperito-
neal injection of acetaminophen in mice expressing an inactive
form of Cot/tpl2 compared with Wt mice, suggesting that Cot/
tpl2 activity contributes to acetaminophen-induced liver injury.
Furthermore, Cot/tpl2 deficiency reduced neutrophil and
macrophage infiltration in the liver of mice treated with acet-
aminophen, as well as their hepatic and systemic levels of IL-1.
Intraperitoneal injection of damage-associated molecular pat-
terns from necrotic hepatocytes also impaired the recruitment
of leukocytes and decreased the levels of several cytokines in the
peritoneal cavity in Cot/tpl2 KOmice compared withWt coun-
terparts. Moreover, similar activation profiles of intracellular
pathwayswere observed inWtmacrophages stimulatedwithWt
or Cot/tpl2 KO damage-associated molecular patterns. How-
ever, upon stimulation with damage-associated molecular pat-
terns, the activation of Erk1/2 and JNKwas deficient in Cot/tpl2
KO macrophages compared with their Wt counterparts; an
effect accompanied by weaker release of several cytokines,
including IL-1, an important component in the development
of sterile inflammation. Taken together, these findings indicate
that Cot/tpl2 contributes to acetaminophen-induced liver
injury, providing some insight into the underlying molecular
mechanisms.
The liver is a crucial metabolic organ and is highly suscepti-
ble to drug toxicity. Acetaminophen (APAP)4 is one of the best-
selling analgesics and antipyretics on the market in the United
States andWestern Europe, although it also accounts for50%
of all cases of acute liver failure (1–3). APAPoverdose generates
N-acetyl-p-benzoquinone imine, which depletes hepatic gluta-
thione and promotes oxidative stress, leading finally to hepato-
cyte necrosis (reviewed inRefs. 4, 5). Necrosis occurswhen cells
die rapidly in response to acute injury, ultimately provoking the
release of intracellular constituents into the surroundingmilieu
(6). Some of these components released belong to a group of
molecules known as damage-associated molecular patterns
(DAMPs). Outside of their physiological environment, these
molecules behave as “danger sensors” and are capable of trig-
gering an inflammatory response in a similar way as previously
described for the pathogen-associated molecular patterns
(PAMPs) (reviewed in Refs. 7, 8). Similar to pathogen-induced
inflammation, sterile inflammation initiated by necrotic cells
alerts the host tissue to host damage by activating the innate
immune system (9, 10). Initially, this process is manifested by
the production of pro-inflammatory mediators and triggering
the recruitment of leukocytes to the damaged tissue (7, 11–13).
However, when excessive, this inflammatory response can con-
tribute to severe organ damage and dysfunction (7, 11, 14).
DAMPs include a wide variety of molecules, and the number of
known DAMPs is growing continually (7, 15–18).
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DAMPs activate a variety of receptor types in different cells,
among which are the members of the pattern-recognition
receptor (PRR) family, including the receptors of the Toll-like
receptor (TLR) family (7, 10, 16, 18, 19). Upon activation, all
TLRs (except TLR3) recruit theMyD88 adaptor protein, which
mediates activation of the p38 and JNK MAP pathways, and
the canonical IKKs, IKK, and IKK (20, 21). Activated IKK
phosphorylates p105 NFB, marking it for partial proteolysis.
In resting cells, Cot/tpl2 (MAP3K8) forms an inactive complex
with p105 NFB and ABIN2, from which Cot/tpl2 is released
following proteolysis of p105 NFB (reviewed in Refs. 22, 23).
The dissociated and activated Cot/tpl2 stimulatesMKK1/2 and
consequently Erk1/2 (24–26), and it is subsequently rapidly
degraded through the proteasome pathway (27, 28). Cot/tpl2 is
the only MAP3K to activate the Erk1/2 pathway in response to
both TLR activation and IL-1 or TNF stimulation (29, 30) in
different cell types, includingmacrophages, epithelial, and stel-
late cells (25, 29, 31). Moreover, Cot/tpl2 can also activate the
MAP kinases JNK and p38 in certain conditions, in a cell type-
and stimulus-specific manner (22, 30). Thus, Cot/tpl2 fulfills a
role in TLR, IL-1, and TNF intracellular signaling that cannot
be substituted by any other protein (22). Accordingly, Cot/tpl2
represents an interesting anti-inflammatory target, given that it
does notmodulate Erk1/2 phosphorylation via the activation of
one or more Raf isoforms (32, 33). Cot/tpl2 contributes to gen-
eration of inflammatory nociception and neutrophil recruit-
ment in mice hindpaw upon zymosan injection (34), promotes
the Crohn-like inflammatory bowel disease (35, 36), and plays a
role in the development of acute pancreatitis (37). However, the
double APC KO Cot/tpl2 KO mice show increased deficiency
intestinal inflammation and tumorigenesis compared with
APCKOCot/tpl2Wt andCot/tpl2 deficiency also increases the
ovalbumin-induced airway allergic response (38).
Here, we show that Cot/tpl2 mediates, both in vitro and in
vivo, DAMP-induced IL-1 production. Cot/tpl2 participates
in the recruitment of leukocytes to damaged tissue in mice
injected intraperitoneally with DAMPs or with a toxic dose of
APAP. Furthermore, APAP-induced liver injury is markedly
reduced in Cot/tpl2-deficient mice. Taken together, these data
indicate that Cot/tpl2 contributes to drug-induced toxicity
associated with cell necrosis.
EXPERIMENTAL PROCEDURES
Cells and Stimuli—ImmortalizedWt and Cot/tpl2 KO hepa-
tocytes were generated from pools of 4–6 livers obtained from
Wt or Cot/tpl2 KO neonatal mice (3.5–4-day-old) that were
digested with collagenase and then cultured. The cells were
subsequently immortalized with the SV40 Large T antigen, as
described previously (39). Hepatocytes were incubated for 18 h
with APAP (Sigma-Aldrich) and/or TNF (Peprotech), and
their viability was then assayed using the MTT kit (Roche),
according to the manufacturer’s instructions. DAMPs were
generated from Wt and Cot/tpl2 KO hepatocytes as described
previously (12, 13) with minor modifications: prior to 1-h heat-
shock at 60 °C, the hepatocytes were washed five times with
PBS and resuspended in DMEM-HEPES. Bone marrow-de-
rived macrophages (BMDM) or peritoneal macrophages were
generated as described previously (26) and then stimulatedwith
DAMPs (300g/ml), LPS (300 ng/ml, Sigma-Aldrich), or PMA
(10 M, Sigma-Aldrich). When necessary, the IKK inhibitor
B1605906 (10M), the JNK inhibitor SP 600125 (12m), or the
Erk1/2 inhibitor PD 0325901 (0.5 M), gifts from Sir Philip
Cohen (Dundee), were added prior to stimulation.
Animals and Animal Treatments—C57BL/6 Wt, C57BL/6
KO, andC57BL/6Cot/tpl2KD littermateswere generated from
the crossing of heterozygous mice (34), and they were used for
experiments at 10–12weeks of age. All animalswere handled in
accordance with institutional guidelines for the care and use of
laboratory animals in research. Themice were fasted overnight
before treatment, and the APAP solution administered (10
mg/ml) was prepared freshly in warmed (55 °C) PBS that was
cooled to 35 °C before it was injected. For survival studies, 600
g/kg APAP (intraperitoneal) was administered to mice. A com-
prehensive laboratory animal monitoring system (TSE) was
used to analyze metabolic behavior 4 h after injection, meas-
uring O2 consumption and CO2 production every 10 min for
48 h. The time of death was determined as the point at which
the respiratory exchange ratio (RER; O2/CO2) became zero or
negative. To evaluate hepatotoxicity the animals were admin-
istered intraperitoneally (i.p.) either with PBS (control) or with
APAP (450 g/kg), food was withheld for 4 h, and at the times
indicated, the mice were sacrificed. Liver tissue was taken from
each mouse, immediately ground into small fragments, frozen
in liquid nitrogen, and stored at 80 °C. Blood was collected,
and the serum was stored at 80 °C until use. The ALT, AST,
and lactate dehydrogenase (LDH) levels were determined (at
the UCM, Madrid), and cytokine levels were assessed by
Luminex analysis (at the CNB, Madrid). Peritoneal leukocyte
recruitment in mice was measured 18 h after injection of liver
homogenate (32 mg, intraperitoneal) or of DAMPs generated
from hepatocytes (1.7 mg, 35 106 cells). Peritoneal cells were
collected as described previously (12, 13, 34). Hepatic non-pa-
renchymal cells were isolated as described previously (40). To
analyze liver damage, tissue sampleswere rinsedwith saline and
fixed by immersion in 4% formalin for 24 h and treated with
hematoxylin and eosin (H&E) staining as described previously
(34). The analysis of the necrotic areas as well as the quantifi-
cation (Image J) of the liver areas with congestive changes occu-
pied by erythrocytes (including the intravascular and hemor-
rhagic areas) were performed in seven randomly selected
microscopic fields from each sample using a10 objective.
Flow Cytometry—Cells (0.3–0.5 106 cells/test) were incu-
bated with CD16/32 (2.4G2, Cultek) for 20 min at room tem-
perature, and they were subsequently stained for 1 h at 4 °C in
the dark with the following antibodies (5 g/ml): CD3-PECy7
(Hamster IgG, eBioscience), CD11a-PECy7 (rat IgG2ak,
Pharmingen), CD11b-(Mac1)-PECy7 (rat IgG2bk anti-mouse,
eBioscience), CD45-FITC (rat IgG, Beckman), F4/80-APC (rat
IgG2ak, eBioscience), Ly6G-PE (rat IgG2ak, Pharmingen), and
NK1.1-APC (mice IgG2ak anti-mouse, Pharmingen), or their
corresponding isotype controls (Pharmingen, eBioscience).
After three washes, Perfect-Count microspheres (Cytognos)
were added to quantify the exact number of cells. Flow cytom-
etry analysis was performed using the CXP program. To deter-
mine the oxidative burst of peritoneal leukocytes, 3 105 cells
were resuspended in PBS, incubated in the dark with 10 M
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2,7-dichlorofluorescin diacetate (Invitrogen), and subse-
quently incubated in the presence or absence of 10MPMA for
15min at 37 °C. After several washes, the cells were analyzed by
flow cytometry.
Western Blot and RT-PCR Analysis—Homogenized liver
extracts and cell extracts were analyzed in Western blots (41),
probed with primary antibodies raised against the following
proteins: Cot/tpl2, Erk2, p38, and p52 JNK2 (Santa Cruz Bio-
technology); P-S933 p105 NFB, P-T202/Y204 Erk1/2, and
P-T180/Y182 p38 (Cell Signaling); and P-T183/Y185 p48/p52
JNK (Invitrogen). Secondary antibodies raised against rabbit
(Cell Signaling), goat (DAKO), and mouse (Amersham Biosci-
ences) were used to detect the primary antibodies. RNA extrac-
tion and RT-PCR analysis were performed as described previ-
ously (42). The specific TAQMAN primers (Applied
Biosystems) IL-1, IL-1, IL-6, IL-10, TNF, and -actin were
used.
Statistical Analysis—Data are presented as the mean S.D.,
and they were analyzed using the Student’s t test. Values were
considered statistically significant at p  0.05: *, p  0.05, **,
p 0.01, ***, p 0.001.
RESULTS
Cot/tpl2 Participates in APAP-induced Liver Damage—Fol-
lowing APAP administration (600 g/kg, intraperitoneal), 12%
survival was observed in Wt mice in the 15 to 30 h following
injection, whereas all the Cot/tpl2 KO mice survived for the
duration of the experiment (Fig. 1A). The serum levels of ALT,
AST, and LDHwere all lower in APAP-treated (450 g/kg, intra-
peritoneal) Cot/tpl2 KO mice than in their Wt counterparts
(Fig. 1B and supplemental Fig. S1). Increased hepatic P-JNK
levels, as a marker of liver damage, were observed 6 h after
APAP-induced liver injury (4, 43), and Cot/tpl2 deficiency
decreased JNK phosphorylation in APAP-injected mice (sup-
plemental Fig. S1). Moreover, the liver of Cot/tpl2 KO mice
revealed a marked histological attenuation of liver injury com-
pared with the severe centrilobular necrosis and hemorrhage
observed inWt animals (Fig. 1C), indicating that Cot/tpl2 defi-
ciency protected againstAPAP-induced hepatotoxicity. InCot/
tpl2 KD mice that express an inactive version of Cot/tpl2 (42),
the levels of AST and ALT after APAP treatment were also
diminished compared with those in Wt mice (Fig. 1D). These
data indicate that APAP-induced liver injury is modulated by
Cot/tpl2 activity rather than by modifications in the Cot/tpl2-
ABIN2-p105 NFB complex, because of Cot/tpl2 knockdown.
APAP-induced liver injury triggers the recruitment of leuko-
cytes to the liver (8, 44, 45). Upon intraperitoneal injection of
PBS, similar numbers of hepatic leukocyteswere detected inWt
and Cot/tpl2 KO mice; yet APAP injection produced a 3-fold
increase in the number of hepatic leukocytes (CD45) in Wt
mice, whereas only a 1.5-fold increase was observed in APAP-
treated Cot/tpl2 KO mice (Fig. 2A). Analysis of the leukocytes
recruited revealed that Cot/tpl2 deficiency mainly decreased
the number of infiltrated neutrophils (Ly6G) and macro-
phages (F4/80: Fig. 2, B and C). In the neutrophils, neither
Cot/tpl2 deficiency nor APAP treatment altered the mean flu-
orescence intensity (MFI) of the CD11a and CD11b activation
markers. However, the macrophages recruited to the liver fol-
lowing APAP administration had a higher CD11b MFI (44), an
effect that was less pronounced in Cot/tpl2 KO macrophages
(Fig. 2D). Following APAP challenge, Cot/tpl2 also triggered
the recruitment of NKT (CD3NK1.1) cells to the liver (Fig.
2B). Moreover, the serum IL-1, IL-1, and IL-6 levels were
lower in APAP-treated Cot/tpl2 KO mice than in Wt mice,
while Cot/tpl2 deficiency promoted an increase in IL-10 levels
(Fig. 3A). Similarly, 6 h upon APAP challenge, the liver of Cot/
tpl2 KO mice showed decreased mRNA levels of IL-1, IL-1,
IL-6, and TNF, but higher IL-10 levels compared with Wt-
treated mice (Fig. 3B).
To determine whether Cot/tpl2 also modulates APAP-in-
duced hepatotoxicity in isolated hepatocytes, immortalizedWt
and Cot/tpl2 KO hepatocytes were incubated with different
concentrations of APAP for 18 h. Similar survival rates were
observed for both Wt and Cot/tpl2 KO cells in the presence of
APAP (supplemental Fig. S2), and although the presence of
TNF alongwithAPAP further increased cell toxicity, Cot/tpl2
did not appear to modulate hepatocyte cell death in either of
these conditions (Fig. 4A). Accordingly, similar LDH levels, as a
consequence of cell necrosis, were detected in the supernatant
of both Wt and Cot/tpl2 KO hepatocytes following incubation
for 18 hwithAPAPplus TNF (Fig. 4B). Furthermore, inAPAP
plus TNF-treated hepatocytes Cot/tpl2 deficiency did not
modulate the activity of JNK (Fig. 4C).
Involvement of Cot/tpl2 in Macrophage Activation by DAMPs—
We evaluated the role of Cot/tpl2 in the activation of thiogly-
colate-elicited peritoneal macrophages by DAMPs obtained
from Wt necrotic hepatocytes. After DAMPs stimulation, a
decrease in IL-10, IL-1, IL-1, IL-6, andTNFwas detected in
the supernatant of Cot/tpl2 KO with respect to Wt peritoneal
macrophages (Fig. 5A). When the activation state of different
intracellular pathways was analyzed in thioglycolate-elicited
peritoneal macrophages stimulated with DAMPs, p105 NFB
phosphorylation, an upstream effector of Cot/tpl2, was simi-
larly increased in both Wt and Cot/tpl2 KO macrophages (Fig.
5B). Moreover, in Wt macrophages, we observed the degrada-
tion of both the high and low molecular weight forms of Cot/
tpl2, suggesting that it had dissociated from the p105 NFB-
ABIN2-Cot/tpl2 complex (26). Stimulation of both Wt and
Cot/tpl2 KO macrophages resulted in an increase in Erk1/2
phosphorylation over 7 min that decreased rapidly in Cot/tpl2-
deficient cells. In Wt peritoneal macrophages but not in Cot/
tpl2 KO cells, a second increase of P-Erk1/2 levels was observed
30 min after stimulation (Fig. 5B). This early Erk1/2 activation
peak following macrophage stimulation with DAMPs was not
due to a possible FBS contamination contained in the DAMPs
(supplemental Fig. S3). Activation of different TLRs in Wt and
Cot/tpl2 KO peritoneal macrophages, as described previously
in BMDM (46), triggered the phosphorylation of p105NFB by
IKK, whereas Erk1/2 phosphorylation was observed only in
Wt macrophages, evident as a single activation peak (supple-
mental Fig. S4). Cot/tpl2 deficiency decreased JNK activation,
but not p38, in peritoneal macrophages stimulated with Wt
DAMPs (Fig. 5B). The loss of Cot/tpl2 expression in Cot/tpl2
KO hepatocytes did not affect the capacity of the obtained
DAMPs to phosphorylate p105 NFB or the different MAP
kinases, as observed when BMDMwere stimulated with Wt or
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Cot/tpl2 KO DAMPs (supplemental Fig. S5). As detected in
peritoneal macrophages (Fig. 5B), the deficient expression of
Cot/tpl2 in BMDMabolished the 30–40min Erk1/2 activation
and decreased JNK phosphorylation following the stimulation
withWt orCot/tpl2 KODAMPs (Fig. 5C and supplemental Fig.
S5). Furthermore, in Wt BMDM stimulated with DAMPs, the
IKK inhibitor B1605906 blocked the activation of Erk1/2 at 40
min but not that at 5 min (Fig. 5D). We previously demon-
FIGURE 1.APAP-induced liver injury inWt andCot/tpl2-deficientmice.A, survival ofWt (n 8) andCot/tpl2 KOmice (n 8) after APAP administration (600
g/kg, intraperitoneal). B, Cot/tpl2 KOmicewere injectedwith APAP (450 g/kg, intraperitoneal), and serumALT and AST levels weremeasured at various times.
Data represent themean S.D. from four experiments performed in quadruplicate. C, Wt and Cot/tpl2 KOmice were injected (450 g/kg, intraperitoneal) with
APAP or with PBS for 24 h. H&E staining of liver sections. Images from PBS-injected mice are representative of three mice, and those frommice that received
APAP are representative of seven animals fromwhich 7 randomly selected fields were analyzed. Scale bars, 100m. Graph shows themean S.E. from the%
congestive area analyzed in 49 different fields obtained from 7APAP-treatedWt, 7 APAP-treated Cot/tpl2 KOmice, and from 3WT PBS-injected and 3 Cot/tpl2
KO PBS-injectedmice. D, Wt and Cot/tpl2 KDmice were injected with APAP (450 g/kg, intraperitoneal), serum ALT and AST levels were determined 18 h later.
Graphs represent the mean S.D. of three independent experiments performed in quadruplicate.
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strated that Erk1/2 activation by LPS is entirely dependent on
Cot/tpl2, whereas Erk1/2 activation by PMA is Cot/tpl2-inde-
pendent (24). Indeed, IKK inhibition blocked LPS- but not
PMA-induced Erk1/2 activation (supplemental Fig. S6).
Together, these data indicate that two distinct intracellular sig-
nal pathways regulate Erk1/2 activation upon DAMPs stimula-
tion of macrophages, one IKK-Cot/tpl2-dependent and
another IKK-Cot/tpl2-independent. Furthermore, taking into
account that Cot/tpl2 deficiency impaired both Erk1/2 and JNK
phosphorylation in DAMPs-stimulated macrophages, we next
decided to investigate the role of both Erk1/2 and JNK MAP
kinases in the production of different cytokines. To this end, Wt
peritoneal macrophages were stimulated for 18 h with DAMPs in
the presence of the JNK inhibitor SP 600125 or in the presence of
the Erk1/2 inhibitor PD 0325901. The measurement of IL-10,
IL-1, IL-1, IL-6, and TNF levels in the different cell superna-
tants suggested that Cot/tpl2 mainly controls the production of
the different cytokines by its capacity tomediate Erk1/2 activation
in DAMPs-stimulatedmacrophages (supplemental Fig. S7).
Cot/tpl2 Modulates Sterile Inflammation in Vivo—Intra-
peritoneal injection of DAMPs induces the recruitment of
leukocytes to the peritoneum (12, 13). Cot/tpl2 deficiency in
mice significantly decreased the peritoneal recruitment of
both macrophages and neutrophils 18 h after intraperitoneal
injection of Wt or Cot/tpl2 KO DAMPs (Fig. 6, A and B).
However, Cot/tpl2 deficiency did not alter the CD11a and
Cd11b MFI values of the cells recruited (supplemental Fig.
S8). Similarly, compared with Wt mice, Cot/tpl2 KD mice
showed reduced peritoneal recruitment of both macrophages
and neutrophils 18 h after intraperitoneal injection of Wt liver
homogenate (supplemental Fig. S9). Oxidative burst analysis of
the Wt and Cot/tpl2 KO peritoneal leukocytes recruited indi-
cated that Cot/tpl2 deficiency slightly reduced their oxidative
burst capacity, a difference that augmented in Cot/tpl2 KO leu-
kocytes upon PMA stimulation (Fig. 6C). On the other hand,
following intraperitoneal injection of Wt DAMPs, peritoneal
levels of IL-1, IL-1, and IL-6 diminished inCot/tpl2 KOmice
compared with their Wt counterparts (Fig. 6D).
FIGURE 2. Leukocyte recruitment in the liver of Wt and Cot/tpl2 KO mice following APAP injection. A, mice were injected intraperitoneally with PBS
(Control) or APAP (450 g/kg), and CD45 liver cells were isolated 18 h later and analyzed by flow cytometry. B, analysis of Ly6G, F4/80, CD3 (CD3NK1.1),
NK1.1 (NK1.1CD3), and NKT (CD3NK1.1) cells from the CD45-gated cells in A. C, representative Ly6G versus F4/80 staining FACS profile from the
CD45-gated cells obtained in A. D, CD11b and CD11a MFI of F4/80 and Ly6G cells isolated from the livers of Wt and Cot/tpl2 KO mice 18 h after
intraperitoneal injectionwith PBS (Control) or APAP (450mg/kg). Graphs represent themean S.D. of one experiment performed in quadruplicate and similar
data were obtained in three additional experiments. Data in A and B represent themean S.D. of four independent experiments performed in quadruplicate.
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DISCUSSION
APAP overdoses are the number 1 cause of acute liver failure
in the Western world, accounting for 50% of them (1–3). The
present study demonstrates the fundamental role of Cot/tpl2
activity in APAP-induced liver damage. APAP-induced liver
injury is associated with sterile inflammation (8, 44, 45), and
Cot/tpl2 participates in its development bymodulating the pro-
duction of cytokines and the liver recruitment of leukocytes. In
this context, it has been previously shown that TLR9 KOmice,
with reduced levels of inflammatory cytokines, show resistance
FIGURE 3.Cot/tpl2modulates cytokine production associatedwithAPAP-induced liver injury.Wt and Cot/tpl2 KOmicewere challengedwith APAP (450
g/kg, intraperitoneal), and cytokines levels were determined. A, serum levels of IL-1, IL-1, IL-6, and IL-10 were determined 18 h later using a Luminex assay.
TNF could not be detected. B, IL-1, IL-1, IL-6, IL-10, and TNFmRNA expression levels upon 6 h of APAP challenge were determined by RT-PCR analysis. A
and B, data represent the mean S.D. of four independent experiments performed in quadruplicate.
FIGURE 4. Toxicity induced by APAP plus TNF in Wt and Cot/tpl2 KO hepatocytes. A, Wt and Cot/tpl2 KO hepatocytes were incubated with 10 ng/ml of
TNF in combination with different concentrations of APAP, and their viability was assessed 18 h later through a MTT assay. The value obtained for Wt and
Cot/tpl2 KO hepatocytes incubated in the absence of APAP was considered as 100%. B, LDH was determined in the cell supernatant of Wt and Cot/tpl2 KO
hepatocytes incubated with 10 ng/ml of TNF plus 20 mM of APAP for 18 h. The 100% value is given to the one obtained after Triton X-100 permeabilization.
C, hepatocytes were incubatedwith 20mM APAP plus 20 ng/ml TNF for 0, 2, and 3 h, and P-JNK and JNK2 levels weremeasured byWestern blot. The relative
relation of P-JNK levels/JNK2 levels was determined by densitometric quantification of the radiographs, given the value of 1 to the one obtained with Wt
hepatocytes at time 0. Similar data have been obtained in three independent experiments. A and B, graphs show the mean  S.D. of three independent
experiments performed in triplicate.
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to acetaminophen toxicity (47). While some controversy sur-
rounds the role of macrophages in the pathogenesis of APAP-
mediated liver damage, neutrophil recruitment has been impli-
cated in this process (40, 48–50). Indeed, neutrophil infiltration
is associated with increased tissue necrosis because of the
release of cytotoxic agents such as reactive oxygen species (51).
APAP overdose generates in hepatocytes the N-acetyl-p-
benzoquinone imine that depletes glutathione and then gener-
ates oxidative stress reactions, leading to hepatocyte necrosis
(4). DAMPs, once released into the surrounding tissue as a con-
sequence of cell necrosis, orchestrate an inflammatory
response, which in many cases can cause a second wave of
destruction contributing to the pathogenesis of many damag-
ing conditions (7, 11, 14). DAMPs are recognized by different
receptors of the PPR family, including differentTLRs (7, 10, 16).
However, the i.p. recruitment of inflammatory cells upon intra-
peritoneal injection of DAMPs is not affected by the loss of a
single TLR (12), although the inflammatory response to
DAMPs is significantly attenuated in IL-1R and MyD88 KO
mice (12). Here, we show that Cot/tpl2 participates in the i.p.
recruitment of leukocytes in response to stimulation with
DAMPs. IL-1R and virtually all TLRs (except TLR3) signal via
MyD88 (20). Indeed, Cot/tpl2, activated via MyD88 or Trif,
triggers the MKK1-Erk1/2 pathway following stimulation of
IL-1R and TNFR and also of all the different TLRs, including
TLR3 (29, 30, 46).
Here we show that Cot/tpl2 once activatedmediates, both in
vivo and in vitro, IL-1 and IL-1 production. Sterile inflam-
mation is largely dependent on IL-1. 	ndeed, sterile inflamma-
tion requires this cytokine to a greater extent than pathogen-
induced inflammation and its role in sterile inflammation
cannot be substituted by IL-1 or any other cytokine (52–55).
The peritoneal recruitment of neutrophils in response to
DAMPs is largely dependent on IL-1 (13), and it has been
recently reported that IL-1 and IL-1 trigger the recruitment
of different myeloid cells (53).
In LPS-stimulated macrophages Cot/tpl2 mediates the pro-
duction of the pro-inflammatory cytokineTNF, but also of the
anti-inflammatory cytokine IL-10 (25, 42, 56), and similar
effects were observed here upon stimulation of macrophages
with DAMPs. However, the contribution of Cot/tpl2 to the
expression of these cytokines in vivo is not as straightforward as
FIGURE 5. Activation of Wt and Cot/tpl2 KO macrophages by DAMPs. A, concentration of different cytokines in the supernatant of Wt and Cot/tpl2 KO
peritoneal macrophages incubated for 18 h in the presence or absence of Wt DAMPs (300 g/ml). The data represent the results of three independent
experiments performed in triplicate. B, Wt and Cot/tpl2 KO peritoneal macrophages were treated as described in A, and at the times indicated, the levels of
P-p105NFB, Cot/tpl2, P-Erk1/2, P-JNK, and P-p38weremeasured inWestern blots. The total Erk2, JNK2, andp38 levelswere determined as protein loading
controls, and one representative experiment of the three performed is shown. C, Wt and Cot/tpl2 KO BMDMwere stimulated withWt and Cot/tpl2 KODAMPs
(300 g/ml), and at the times indicated, the cell extracts were analyzed in Western blots probed with the antibodies indicated in B. The P-p105 NFB/Erk2,
P-Erk1/2/Erk2, P-JNK/JNK2, and P-p38/p38 values are expressed relative to theWt time 0 point, and the data in the graphs represent themean S.D. from
four independent experiments. D, Wt BMDMwere stimulated with Wt DAMPs (300g/ml) in the absence (Control) or presence of 10M of the IKK inhibitor
(IKK I) B1605906 for the indicated times. Subsequently P-Erk1/2 and Erk2 levels were determined byWestern blot analysis. The graphs represent themean
S.D. from three independent experiments of P-Erk1/2 fold induction relative to the Wt time 0 point, after normalizing values to, respectively, total Erk2.
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that observed in individual isolated cells. Cot/tpl2 controls
TNF synthesis upon i.p. injection of LPS/D-galactosamine in
mice (25) but not following zymosan-induced intraplantar
inflammation or following an infection with Listeria monocy-
togenes (34, 57). Conversely, Cot/tpl2 deficiency in APC KO
mice results in a decrease in serum IL-10 (58), while in LPS and
CpG-DNA-treated mice, Cot/tpl2 blocks IL-10 production
(59). Our findings demonstrate that Cot/tpl2 only mildly
increases peritoneal IL-10 levels upon injection with DAMPs,
and it decreases serum IL-10 levels in response to APAP-in-
duced liver injury. Although IL-10 protects against APAP-in-
duced liver injury (60), it remains to be determinedwhether the
FIGURE 6. Leukocytes recruitment following DAMPs-induced peritonitis inWt and Cot/tpl2 KOmice. Animals were injected (intraperitoneal) with Wt or
Cot/tpl2 KO DAMPs (1.7 mg) or with PBS (Control), and peritoneal cells were isolated 18 h later. A, number of isolated peritoneal macrophages (F4/80) and
neutrophils (LY6G) recoveredafter injectionofWtorCot/tpl2KODAMPs inWtandCot/tpl2KOmice.B, one representative Ly6G versusF4/80 stainingFACS
profile ofWt andCot/tpl2 KOperitoneal cells isolated 18 h after injection ofWtDAMPs inWt andCot/tpl2 KOmice.C, oxidative burst activity of isolatedWt and
Cot/tpl2 KO peritoneal cells incubated in the presence or absence of PMA (10 M) in vitro. The relative induction is expressed in terms of that obtained in
unstimulated Wt cells. D, levels of the indicated cytokines in the peritoneal cavity of Wt and Cot/tpl2 KO mice treated as described in B. A, C, and D, graphs
represent the mean S.D. of three independent experiments performed in triplicate.
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increased levels of IL-10 in Cot/tpl2 KO mice at least in part
attenuate liver injury.
Tissue damage is recognized at the cell level. Different
DAMPs are recognized by the different receptors of the PPR
family. The failure of DAMPs from necrotic cells to express
specific molecules modifies their capacity to develop sterile
inflammation (7, 15–18). However, dampenedCot/tpl2 expres-
sion in hepatocytes does not affect the capacity of their
obtained DAMPs to activate macrophages in vitro or to initiate
the sterile inflammation response in vivo.
Sterile inflammation is initiated by DAMPs that upon stim-
ulation of different cell types including macrophages (12), pro-
duce IL-1 a major regulator of sterile inflammation (52–55).
Inmacrophages, DAMPs activate Erk1/2, and our data indicate
that Cot/tpl2mediates the activation of Erk1/2 after 30min but
not after 5 min following stimulation. This rapid increase in
Erk1/2 phosphorylation is probably mediated by the activation
of another MAP3K, most likely one of the RAF proteins. Cot/
tpl2 is the only MAP3K to activate the Erk1/2 pathway in
response to both TLR activation and IL-1 or TNF stimulation
(29, 30). However, cell stimulation with DAMPs results in acti-
vation of a variety of receptors (7), thus the two different intra-
cellular pathways involved in Erk1/2 phosphorylation under
this cellular condition. Cot/tpl2 can also activate JNK (22, 30),
and here we show that Cot/tpl2 partially mediates JNK phos-
phorylation upon macrophage activation with DAMPs. How-
ever, the decreased production of cytokines in themacrophages
from Cot/tpl2 KO mice is due to impaired activation of the
Erk1/2 intracellular signal pathway. In conclusion, our data
show that Cot/tpl2 participates in sterile inflammatory path-
ways triggered by damaged tissue and plays an essential role in
APAP-induced liver injury.
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